ArriVent BioPharma Overview
ArriVent BioPharma Target Price
Analysts' 12-month price predictions for AVBP.
Get informed when a big investor buys or sells
+ FollowShare Price
$29.78
Average Target Price
$45.00
51.1% upside
51.1% upside1 analysts in the last 4 months
High: $45 | Low: $45
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2026-05-29 | Truist Financial | $45 | 51.1% upside |  |
| 2025-12-10 | BTIG | $45 | 51.1% upside | |
| 2025-11-25 | Truist Financial | $43 | 44.4% upside | |
| 2025-07-10 | Goldman SachsCorinne Johnson | $33 | 10.8% upside | |
| 2024-09-10 | CitigroupYigal Nochomovitz | $36 | 20.9% upside | |
| 2024-09-10 | H.C. WainwrightRobert Burns | $36 | 20.9% upside | |
| 2024-08-16 | H.C. WainwrightRobert Burns | $30 | 0.7% upside | |
| 2024-07-22 | OppenheimerJeff Jones | $35 | 17.5% upside | |